Beigene, Ltd. (NASDAQ:ONC) Director Bros. Advisors Lp Baker Sells 732,827 Shares

Beigene, Ltd. (NASDAQ:ONC) Director Bros. Advisors Lp Baker sold 732,827 shares of the firm’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $260.00, for a total value of $190,535,020.00. Following the sale, the director now directly owns 730,642 shares in the company, valued at $189,966,920. The trade was a 50.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Beigene Stock Down 2.4 %

Shares of Beigene stock opened at $271.80 on Friday. The firm has a market cap of $26.60 billion, a P/E ratio of -32.99, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63. Beigene, Ltd. has a 12 month low of $126.97 and a 12 month high of $287.88. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93.

Beigene (NASDAQ:ONC) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($1.43) EPS for the quarter, missing the consensus estimate of ($0.88) by ($0.55). Beigene had a negative return on equity of 25.12% and a negative net margin of 25.94%. The business had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.09 billion. As a group, research analysts anticipate that Beigene, Ltd. will post -5.82 earnings per share for the current year.

Analyst Ratings Changes

Separately, Macquarie raised their price objective on Beigene from $259.00 to $313.00 and gave the stock an “outperform” rating in a research note on Friday.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.